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Abstract
The analysis of randomized trials with time-to-event endpoints is nearly always plagued by
the problem of censoring. As the censoring mechanism is usually unknown, analyses typically
employ the assumption of non-informative censoring. While this assumption usually becomes
more plausible as more baseline covariates are being adjusted for, such adjustment also raises
concerns. Pre-specification of which covariates will be adjusted for (and how) is difficult,
thus prompting the use of data-driven variable selection procedures, which may impede valid
inferences to be drawn. The adjustment for covariates moreover adds concerns about model
misspecification, and the fact that each change in adjustment set, also changes the censoring
assumption and the treatment effect estimand. In this paper, we discuss these concerns and
propose a simple variable selection strategy that aims to produce a valid test of the null in
large samples. The proposal can be implemented using off-the-shelf software for (penalized)
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Cox regression, and is empirically found to work well in simulation studies and real data
analyses.
Keywords— causal inference, censoring, variable selection, post-selection inference, double selection
1 Introduction
Randomized trials on the effect of treatment on time-to-event endpoints are typically plagued by dropout
or intercurrent events, resulting in censored event times. The logrank test constitutes the gold standard
for the design (in determining sample size) and analysis of such data (e.g. Lin and Leo´n, 2017; Halabi
and Michiels, 2019) under the assumption that censoring is non-informative in each treatment arm. This
assumption is strong but can usually be relaxed via adjustment for prognostic baseline covariates, which
moreover tend to yield increased power in randomized controlled trials (Herna´ndez et al., 2006). Even so,
unadjusted analyses still dominate the evaluation of primary endpoints in practice (Austin et al., 2010; Yu
et al., 2010). The reason is that covariate adjustment demands (proportional hazards) modelling, which
raises concerns about model misspecification bias and the difficulty in pre-specifying which covariates to
adjust for and in which functional form.
Interestingly, model misspecification appears not to be a major concern for testing the null hypothesis
of no treatment effect in randomized experiments. In particular, standard tests obtained under a Cox
proportional-hazards model are valid in spite of misspecification, so long as a sandwich estimator of the
variance is used (e.g. Lin and Wei, 1989; Kong and Slud, 1997; DiRienzo and Lagakos, 2001). However,
this robustness is attained only when censoring is either independent of the treatment conditional on the
covariates, or independent of covariates in each treatment arm (e.g. Kong and Slud, 1997; Lagakos and
Schoenfeld, 1984; DiRienzo and Lagakos, 2001). These assumptions are stronger than one is typically
willing to make in practice. Variable selection procedures (eg, based on hypothesis tests, AIC or the Lasso)
can help in choosing a model and thereby temper concerns about misspecification. Data-driven selection
is however known to typically inflate the Type I error of the test of no treatment effect, as we will also
demonstrate in this article. Although several methods have been proposed to deal with this problem
of inference after variable selection (Ning et al., 2017; Fang et al., 2017; Chai et al., 2019), little work
has specifically focused on Type I error rate control in randomized experiments with censored data. In
particular, to the best of our knowledge, little or no attention has been given to the fact that each change
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in adjustment set, also changes the censoring assumptions as well as the treatment effect estimand.
In view of this, we will here propose a simple variable selection method which controls the Type I
error of the test of no treatment effect and evaluate the impact of selection on estimating marginal survival
curves.
2 The Impact of Variable Selection
Let T denote the time from randomization to event and C the censoring time. We observe (T ∗, δ) , where
T ∗ = min(T,C) is the observed portion of T and δ = I(T 6 C) is a censoring indicator. Let the binary
random variable A denote the treatment group and let X denote a covariate that for the moment is scalar.
Throughout this paper we assume that A is independent of X by virtue of the randomization and that
censoring is non-informative conditional on A and X in the sense that T ⊥ C|(X,A). We are interested in
testing the null hypothesis that the event time distribution does not depend on the treatment group.
To develop insight into the aforementioned concerns about variable selection, suppose that the following
Cox model
λ (t | A,X) = λ0(t)eαA+βX , (1)
is correctly specified, and that censoring is non-informative conditional on A and X. Here, λ0(t) is the
unspecified baseline hazard function, and α encodes the treatment effect of interest. Likewise, suppose that
the model for censoring obeys
λC (t | A,X) = λC0 (t)eγ1A+γ2X , (2)
where λC0 (t) is the baseline hazard function.
In practice, it is difficult to know a priori whether adjustment for X in model (1) is required in order
to do inference for α. We therefore typically need to decide between fitting the unrestricted model (1), or
the restricted model:
λ (t | A) = λr0(t)eα0A, (3)
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where λr0(t) is the baseline hazard function.
Routine practice to decide whether to adjust for X, is often based on data-adaptive covariate selection
strategies. These employ the data to make a binary decision D on whether to report the p-value pα (when
D = 1), corresponding with the test statistic (denoted by Zα) for the null hypothesis that α = 0 in the
unrestricted model (1) or to report the p-value pα0 (when D = 0), corresponding with the test statistic
(denoted by Zα0) for the null hypothesis that α0 = 0 in the restricted model (3). For instance, it is common
to adjust for X if and only if it is significantly (eg, at the 5% level) associated with the survival endpoint
conditional on the treatment A. In this case, D = I(pβ < 0.05), where pβ is the p-value corresponding with
the null hypothesis that β = 0. Thus, for scalar X, routine practice is based on reporting the following,
so-called post-model-selection p-value for the parameter of interest α
p˜α =
 pα if D = 1pα0 if D = 0. (4)
Note that these p-values are obtained under different censoring assumptions. In particular, under model
(3) we implicitly make the stronger assumption that censoring is independent of the event time in each
treatment arm. As T ⊥ C | A,X does not imply T ⊥ C | A, failing to control for the baseline covariate X
by prioritising the unadjusted analysis, as is common, or as a result of variable selection errors, may induce
informative censoring. Selecting model (3) may therefore lead to bias in the corresponding test statistic
Zα0 . As a consequence, the test statistic corresponding with the p-value in (4)
Z˜α =
 Zα if D = 1Zα0 if D = 0,
generally has a complex, bimodal distribution that may sharply deviates from the standard normal distribu-
tion. This is the result of the test statistic jumping back and forth between the test statistics Zα and Zα0 ,
where the distribution of the latter might not be centered at zero (ie, is biased) as a result of informative
censoring when not adjusting for X (model (3)).
For the more technical reader, it is shown in Appendix A.1 that, when failing to select the covariate X,
the bias of the (score) test statistic under the null hypothesis of no treatment effect (See (7) in Appendix
A.1) has a leading term that is proportional to βγ2. This bias is problematic as it may inflate the Type I
error of the corresponding score test (Leeb and Po¨tscher, 2006). This happens primarily if it has the same
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order of magnitude as the standard error of the mean score as is the case when βγ2 has order of magnitude
equal to or larger than a/
√
n for some constant a. For example, when β = b/
√
n for some constant b and
γ2 is large, or vice versa. This is illustrated in Figure 8 of Appendix B, which shows the distribution of
the score test statistic when failing to control for X (which corresponds to the logrank test statistic) for
different values of β, γ1 and γ2. The problem of bias is most pronounced when β, γ1 and γ2 are large and
disappears when either at least one of the coefficients is zero or both β and γ2 are small.
Figure 1: Empirical Type I error rate at the 5% significance level under covariate selection at the
2.5% significance level in function of β, γ1 and γ2. Results are based on 5000 simulations, n = 100,
X ∼ N(0, 1), λ0(t) = e and λC0 (t) = e−1.
To appreciate the severity of the problem, Figure 1 summarizes the Type I error under hypothesis-based
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covariate selection at the 2.5% significance level for different values of β, γ1 and γ2. First, note that the
nominal Type I error rate is maintained when A is independent of C conditional on X (top-left panel).
When A and C are associated conditional on X, the problem of inflated Type I error is most pronounced
when X has a strong effect on C (high γ2) but a weak-to-moderate effect on T (low β). This is because
the variable selection procedure likely fails to pick up X when it is only weakly predictive of the survival
time, as a consequence of the information loss induced by censoring as well as the fact that censoring may
even reduce the variation in X in the risk set. This in turn induces informative censoring, which may lead
to bias in the corresponding test statistic and hence to inflated Type I errors. This problem becomes more
severe for larger values of γ1 (aka when A is highly predictive of censoring).
Surprisingly, these standard variable selection procedures do not affect tests of the null hypothesis of
no treatment effect in generalised linear models for uncensored outcomes (Wager et al., 2016; Dukes et al.,
2020), but they here arise due to the change in censoring assumption with each change in adjustment set.
This is the case regardless of whether selection is done through hypothesis testing (eg, stepwise regression)
or related approaches such as the Lasso. Although the extent of Type I error rate inflation is less severe
with increasing sample size, at any sample size there may be values of β that are small but different from
zero so that they will be missed by the variable selection procedure. As we don’t know the underlying
data-generating mechanism and as the problem may potentially get worse with multivariate X, it will be
difficult to know in advance whether we have enough data to guarantee selection of the right variables in
order to control for informative censoring and hence Type I error inflation. In the next section, we therefore
propose a simple method that has a better chance of selecting the right variables and thereby controlling
the Type I error.
3 Proposal for Variable Selection
In order to prevent inflated Type I errors, we recommend using a “double selection” approach (Belloni
et al., 2013) based on the Lasso. Double selection was developed in the context of selection of possible
confounders for inclusion in the analysis of observational studies. It uses two steps to identify covariates
for inclusion, first selecting variables that predict the outcome of interest and then those that predict the
exposure/treatment. Using similar ideas, our proposal will rely on the selection of variables associated with
either survival or censoring (or both).
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In particular, let X now be the p-dimensional vector of baseline covariates (X1, . . . , Xp)
′, adjustment for
which we assume to be sufficient to render censoring independent. For the remainder of the paper, we will
focus on the Lasso to select covariates since it is known to perform well with a large number of covariates
and it can now be implemented easily in many statistical software packages. However, our proposal can
allow for more general variable selection procedures. Building on the idea of double selection, we perform
a two stage selection procedure followed by a final estimation step as follows:
1. Fit a Cox model for survival time T on the treatment A and baseline covariates X using Lasso
(penalising all coefficients in the model), and select the covariates with non-zero estimated coefficients:
λ (t | A,X) = λ0(t)eαA+β
′X
2. Fit a Cox model for censoring C on the treatment A and baseline covariates X using Lasso (penalising
all coefficients in the model), and select the covariates with non-zero estimated coefficients:
λC (t | A,X) = λC0 (t)eγ1A+γ
′
2X
3. Fit a Cox model for the survival time on the treatment A and all covariates selected in either one of
the first two steps:
λ (t | A,XU ) = λ∗0(t)eα
∗A+β∗
′
XU ,
with XU the covariates estimated to have non-zero coefficients in Steps 1 and/or 2. Inference on
the treatment effect α∗ may then be performed using conventional methods, provided that a robust
standard error is used.
Note that the last regression may also include additional variables that were not selected in the first two
steps, but that were identified a priori as being important.
Our proposal differs from standard methods that rely on a single selection step by introducing this extra
(second) step. This step helps to identify variables that are weakly-to-moderately predictive of survival but
strongly related to censoring. As shown in Section 2, eliminating these variables may induce informative
censoring, even if all common causes of survival and censoring are measured, and this may in turn inflate
Type I errors. Our procedure will only reject covariates that are weakly associated with both survival and
censoring; asymptotically, this is not problematic because the omission of such covariates induces such weak
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degrees of informative censoring that the resulting bias in the test statistic for the null will be small enough
that inference is not jeopardised (see Section 2).
The above proposal is closely linked to a more rigorous method proposed by Fang et al. (2017) for
observational studies. These authors construct a decorrelated score function by applying a projection of
the score function of the parameter of interest α under model (1) orthogonal to the nuisance tangent space.
In addition to Step 1 of our proposal, this involves fitting a weighted linear model for the treatment in the
risk set across all time points. In this approach, the predictors of censoring are indirectly picked up via
the treatment model as such predictors become associated with treatment in the risk sets over time. Our
proposal is motivated by the fact that the treatment is randomised (at baseline) and that score tests under
a Cox model for censoring have more power to pick up predictors of censoring. For more details we refer
the interested reader to Appendix A.3 and Fang et al. (2017).
4 Monte Carlo Simulations
In this section, we compare the finite-sample Type I error rate of the logrank test statistic, the test statistic
based on the proposed double selection strategy and that based on the post-Lasso approach, which refits
the Cox model to the variables selected by the first-step penalized variable selection method (ie, Lasso).
The last two considered approaches require the selection of penalty parameters and base inference for the
treatment effect parameter on the robust standard error. In our simulation study, we use a 20-fold cross
validation technique with the negative cross-validated penalized (partial) log-likelihood as the loss function.
We obtain the two default penalty parameters λmin, which gives minimum mean cross-validated error, and
λ1se, which is the largest value of the penalty parameter such that the cross-validated error is within 1
standard error of the minimum, using the function cv.glmnet() in the R package glmnet.
In the simulation studies, we generate n mutually independent vectors
{
(Ti, Ci, Ai, X
′
i)
′}
, i = 1, . . . , n.
Here, Xi = (Xi,1, . . . , Xi,p) is a mean zero multivariate normal covariate with covariance matrix Ip×p. The
binary treatment Ai is Bernoulli distributed with probability 0.5 and the ith survival and censoring time
are based on the following distributions:
Ti
d
= exp(λT,i), with λT,i = exp(β0 + β
′Xi)
Ci
d
= exp(λC,i), with λC,i = exp(γ0 + γ1Ai + γ
′
2Xi),
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where β0, γ0 and γ1 are scalar parameters, and β = b ·νT and γ2 = g ·νC are p-dimensional parameters with
b and g scalar and νT and νC p-dimensional parameters. In our study, we consider the following coefficient
vectors νT and νC
1. νT = (1, 1/2, . . . , 1/9, 1/10, 011, . . . , 0p)
′,
νC = (1, 1/2, 1/3, 1/4, 1/5, 1, 1/2, 1/3, 1/4, 1/5, 011, . . . , 0p)
′,
2. νT = (1, 1/2, 1/3, 1/4, 1/5, 1, 1/2, 1/3, 1/4, 1/5, 011, . . . , 0p)
′,
νC = (1, 1/2, . . . , 1/9, 1/10, 011, . . . , 0p)
′,
3. νT = (1, 1/2, 1/3, 1/4, 1/5, 1, 1/2, 1/3, 1/4, 1/5, 011, . . . , 0p)
′,
νC = (1/5, 1/4, 1/3, 1/2, 1, 1/5, 1/4, 1/3, 1/2, 1, 011, . . . , 0p)
′,
where the subscripts indicate the index (i.e., position) of 0 in the vector. The coefficients νT and νC are used
to control the association between the covariates and respectively the survival and censoring times. The
coefficients β0 and γ0 are set equal to 0, corresponding with λ0(t) = 1. For the data generating mechanisms
described above, we perform 1, 000 Monte Carlo runs for n = 400 and p = 30. In these set-ups, the
coefficients feature declining patterns, with the smallest coefficients being hard to distinguish from zero at
the given sample size. Therefore, we would expect the single step model selection procedure to mistakenly
remove variables with smaller coefficients.
The empirical type I errors for Setting 1 are summarized in Figure 2 and Figure 3. First, note that the
Type I error is maintained for all considered tests when no baseline covariate is simultaneously associated
with both C and T (ie, b = 0 or g = 0; see Section 2). Moreover, the empirical Type I errors of the
different tests are close to the desired significance level of 5% for γ1 = 0. For values of γ1 deviating from
zero, the Type I error rate of the logrank test is highly inflated throughout large parts of the parameter
space (see Figure 3). This subspace as well as the inflation itself, become larger with stronger strength of
association between A and C (ie, absolute value of γ1). Surprisingly, the na¨ıve test based on the post-Lasso
still performs reasonably well for γ1 close to zero. However, better results are achieved using our proposal
(see column 2 in Figure 2). When γ1 = 3, the Type I error rates based on the post-Lasso selection deviate
strongly from the desired significance level of 5% throughout large parts of the parameter space (Rows 3
and 4 in Figure 2). This is a result of eliminating too many covariates from the outcome model (Rows
3 and 4). Although using the value of the penalty parameter that gives minimum mean cross-validated
error (ie, λmin) tends to improve the results (Row 4), it does not resolve the problem entirely. In contrast,
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Figure 2: Empirical Type I error rate at the 5% significance level of the post-Lasso and the proposed
double selection method under Setting 1. Row 1: double selection method with penalty parameter
λ1se; Row 2: double selection method with penalty parameter λmin; Row 3: Post-Lasso with penalty
parameter λ1se ; Row 4: Post-Lasso with penalty parameter λmin. Left: γ1 = 0; Middle: γ1 = 1;
Right: γ1 = 3. Results are based on 1, 000 simulations, n = 400, p = 30, λ0(t) = 1 (β0 = 0) and
λC0 (t) = 1 (γ0 = 0).
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Figure 3: Empirical Type I error rate at the 5% significance level of the logrank test under Setting
1. Left: γ1 = 0; Middle: γ1 = 1; Right: γ1 = 3. Results are based on 1, 000 simulations, n = 400,
p = 30, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
the empirical Type I errors of both tests based on double selection (Row 1 and 2) are substantially closer
to the desired significance level of 5%, which confirms our expectations. This holds across the different
parameter values considered. In addition, although the proposal seems to have best performance with λ1se,
the simulation results for the proposal are less sensitive to the choice of the penalty parameter (ie, λmin or
λ1se) compared to the post-Lasso approach. We refer the readers to Appendix B for the detailed results
under Setting 2 and 3.
5 Understanding the Selection Bias due to Censoring
While the double selection proposal performs well across the different data generating mechanisms consid-
ered, somewhat surprisingly the Type I error of the na¨ıve Lasso-based test is almost as accurate in several
settings. To develop insight into this, we will use causal diagrams. For pedagogical purposes, we will focus
on settings with a single covariate.
Surprisingly the validity of the three tests of the null hypothesis of no treatment effect is maintained
even if censoring does depend on survival time, as long as censoring is independent of treatment. To see
why, in a Directed Acyclic Graph (DAG), if indeed A has no causal effect on T and C (which is the case
since there is no arrow going from A to T or from A to C), then, even if censoring depends on the survival
time through the backdoor pathway C ← X → T , there is no path connecting A and T in the risk set at
each time point (see Figure 4c). This means that, even if censoring is strongly informative, no systematic
association between A and T could be observed, and hence a valid test of the null will be obtained. Analyses
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A TC
X
(a) Non-informative censoring and A 6⊥ C
A TC
X
(b) Non-informative censoring and A 6⊥ C
A TC
X
(c) Informative censoring and A ⊥ C
A TC
X
(d) Informative censoring and A 6⊥ C
Figure 4: DAGs under different censoring mechanisms.
unconditional on X are valid under the null hypothesis if censoring is (statistically) independent of survival
time (see Figures 4a and 4b). This validity, however, breaks down when censoring does depend on A and
T . To see why, note that the hazard, by definition, conditions on being in the risk set. In particular,
once censoring is involved, then by conditioning on the risk set, one is also conditioning on patients being
uncensored. If we consider the causal diagram in Figure 4d, it is clear that we thereby condition on a
‘collider’, thus opening a spurious association between treatment A and X in the risk set at each time
point. This phenomenon, where a distorted association between treatment A and outcome T is induced
when in fact none exists, is better known as collider stratification bias (Greenland et al., 1999). This can
lead to inflated Type I error rates.
This can also be seen in the expression for (the bias in) the score (Equation 5) in Appendix A.1, which
equals zero if either C is independent of T (corresponding with β = 0 or γ2 = 0) or C is independent of A
(corresponding with γ1 = 0). This is also shown more rigorously in Appendix A.2.
To summarize, theory suggests that failing to adjust forX is only problematic in settings where censoring
is informative (due to X) and depends on treatment. In particular, the logrank test is a valid test of the
null if censoring is either independent of treatment or independent of the survival time in each treatment
arm. Correspondingly, in settings where censoring depends on treatment and survival, variable selection
approaches may induce an inflated Type I error if they fail to pick up a common cause of C and T . As
biases from collider-stratification often tend to be much smaller than confounding bias (Greenland, 2003),
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the inflation in Type I error tends to be more limited than that due to selecting confounders in observational
studies. This explains why the post-Lasso is performing reasonably well in several settings where one would
expect it to fail; ie, in settings where (some) variables are weakly associated with T and strongly associated
with C (see Section 4). In particular, its inflation in Type I error is only severe when censoring is strongly
associated with treatment and informative. Even so, the proposed double selection approach, by making it
more likely to pick up the right variables, controls the Type I error better, even in these more extreme yet
plausible settings.
The previous results suggest that we can obtain valid tests of the null hypothesis of no treatment effect
under different data-generating mechanisms, even if we fail to adjust for (certain) baseline covariates. As
we will see, this does not imply that Kaplan-Meier curves or marginal survival curves obtained via the Cox
model after na¨ıve (eg, post-Lasso) selection are unbiased. This is important as investigators are increasingly
encouraged to also present marginal survival curves rather than just testing the null hypothesis (Austin,
2014). In the following section, we therefore discuss the implications for estimated survival curves and give
a proposal to reduce bias in estimated survival curves after variable selection.
6 Implications for Estimated Survival Curves
Unbiasedness of the Kaplan–Meier estimator relies on the assumption that there is no dependence between
time to event T and censoring C. To illustrate the possible bias under dependent censoring, Figure 5
shows the traditional Kaplan-Meier estimator and the true survival curves for a simulated dataset in which
covariates are associated with both time to event and time to censoring. Note that Kaplan-Meier survival
curves are biased if treatment has no effect on both censoring and survival, but in the same way across
treatment groups. In particular, there is then no difference between the observed curves in both treatment
arms (in large samples), regardless of whether survival and censoring are independent (see Figure 5a). As
shown in Figure 5b, the validity of the logrank test is no longer maintained if censoring depends on both
treatment and survival. In that case the two observed curves no longer overlap.
It follows from the above that correction for dependent censoring is more important to obtain valid/interpretable
survival curves than it is to test equality of survival curves in two treatment arms. To avoid bias, regression
standardization -also referred to as ’directly adjusted survival curves’ (Gail and Byar, 1986)- based on a
model that includes all variables necessary to render T independent of C can then be employed (Rothman
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(a) Censoring independent of treatment (b = 1,
γ1 = 0 and g = 2).
(b) Censoring dependent on treatment (b = 1,
γ1 = 2 and g = 2).
Figure 5: True and estimated Kaplan-Meier surival curves under an informative-censoring setting.
Data are simulated under Setting 1 (see Section 4). Results are based on one dataset with n =
100, 000, p = 30, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
et al., 2008). This method uses the regression model to predict the risk of survival at each time, for treated
and untreated/controls separately, at every observed level of the measured baseline covariates. These pre-
dictions are then averaged over the baseline covariate distribution observed in the sample to produce the
survival function under treatment and control.
We performed a limited simulation study to evaluate the performance of standardized survival curves
based on post-Lasso and double selection. Figure 6 compares standardized survival curves to the true and
Kaplan-Meier survival curves evaluated at 13 timepoints (0, 0.5, . . . , 5.5, 6) under treatment. We see that
standardization reduces bias in the estimated survival curves, with the ones based on the proposed double
selection approach closest to the real survival curve in all settings. This improved performance is due to
the higher chance of selecting the right variables; ie, the variables that are associated with both survival
and censoring. This in turn reduces the impact of selection bias. We repeated these simulations for several
different data generating mechansims. Since the results were largely unchanged, the additional results are
shown in Figures 12 and 13 in Appendix B.
Although the combination of double selection and regression standardisation performed well in simu-
lations, it lacks a rigorous justification. An alternative with better theoretical justification would be to
use augmented inverse probability of censoring weighting (AIPCW) (Robins and Rotnitzky, 1992) with
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(a) Censoring independent of treatment (b = 0.8,
γ1 = 0 and g = 1.6).
(b) Censoring dependent on treatment (b = 0.8,
γ1 = 2 and g = 1.6).
Figure 6: True survival curves, unadjusted (Kaplan-Meier based) survival curves and ad-
justed/standardized survival curves based on the post-Lasso and double selection models evalu-
ated at 13 timepoints (0, 0.5, . . . , 5.5, 6). Results are shown for A = 1 based on 1, 000 simulations
under Setting 1 (see Section 4), n = 400, p = 30, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
Truth: True survival curves; Unadjusted: unadjusted/Kaplan-Meier survival curves; Double Selec-
tion: standardized survival curves based on double selection model with penalty parameter λ1se;
Double Selection Min: standardized survival curves based on double selection model with penalty
parameter λmin; Lasso: standardized survival curves based on Post-Lasso model penalty parameter
λ1se ; Lasso Min: standardized survival curves based on Post-Lasso model with penalty parameter
λmin.
separately fitted Cox models for the time to event and censoring. The resulting estimators, by virtue of
being double robust, are not sensitive to the use of standard variable selection procedures, provided that
both Cox regression models are correctly specified, for similar reasons as in Farrell (2015).
Whilst the AIPCW methodology, combined with data-adaptive estimation of nuisance parameters, will
likely play an important role in future methodological developments, the focus of this article is how to
improve upon standard practice in the analysis of trials with time-to-event endpoints. We have given
attention to simple methods that can be implemented using tools familiar to trial statisticians; the use
of weighting-based approaches (as well as machine learning for time-to-event endpoints) is currently not
widespread. Moreover, in settings where covariates and treatment are strongly predictive of censoring, our
proposal may yield better finite sample performance compared with AIPCW estimators by avoiding the
use of weights (which can become extreme), despite the lack of theoretical justication.
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7 Data Analysis
We illustrate the proposal on data from the PBC-3 trial (Lombard et al., 1993), a multicenter randomized
clinical trial conducted in six European hospitals with patient accrual between January 1983 and January
1987. In this period, 349 patients with the liver disease primary biliary cirrhosis (PBC) were randomized
to either treatment with Cyclosporin A (CyA, 176 patients) or placebo (173 patients). The purpose of
the study was to investigate the effect of treatment with CyA (compared to placebo) on the survival time.
An increased use of liver transplantation for patients with this disease made the investigators redefine
the main response variable to be time to “failure of medical treatment” defined as either death or liver
transplantation. At entry a number of possible prognostic factors were measured: histological stage (1-2-3-
4), previous gastrointestinal bleeding (yes/no), creatinine (micromoles/L), serum bilirubin (micromoles/L),
serum albumin (g/L), alkaline phosphatase (IU/L), aspartate transaminase (IU/L), body weight (kg), age
(years) and sex.
An unadjusted analysis comparing survival between the two arms (where patients receiving transplant
were censored) showed no statistical differences between the two arms (Logrank with robust SE p = 0.88).
The same was true for an additional test for the combined outcome of progression to death or transplant
(Logrank with robust SE p = 0.78). In the original study, the possibility of a chance imbalance between the
arms at entry with respect to important prognostic factors motivated Lombard et al. (1993) to conduct a
multivariate analysis. Variables for the Cox proportional hazards regression model were identified by back-
ward elimination procedures. Cox multivariate analysis showed time from entry to death or transplantation
was significantly prolonged in the CyA-treated group compared to placebo. On the other hand, for the Cox
model with death as the sole endpoint (transplants censored), no significant effect of treatment was found.
A multivariate analysis can take these imbalances into account, but is recommended even more generally.
This because the assumption of non-informative censoring is more plausible conditional on covariates; hence
a log rank test may not be valid.
A complication of multivariate analysis is that data may be missing for certain patients on one or more
baseline covariates. This was the case here: the percentage of patients with missing data on histological
stage was 16.6 (58 our of 349). In view of this, we first selected variables using the 275 complete cases
(141 in CyA arm and 134 in placebo arm), and then performed multiple imputation before conducting
all regression analyses. While this approach may not be optimal (Wood et al., 2008), it improves upon
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fitting adjusted Cox models using complete cases only. Five different imputed datasets were created for
each endpoint separately. The imputed values were obtained using the function smcfcs in the eponymous
package, which imputes missing values of covariates using Substantive Model Compatible Fully Conditional
Specification (Bartlett et al., 2015). On each imputed dataset, we then fitted a Cox model for time to
the considered endpoint (ie, all deaths or the combined endpoint) on treatment and the variables selected
either by i) the Lasso and ii) the double selection approach. After analyzing each imputed dataset, the five
sets of results were pooled using Rubin’s Rules (Rubin, 1987). At the selection stage, we used the grouped
LASSO offered by the grpreg package in order to deal with categorical predictors in LASSO regression.
Considering main effects only, performing post-Lasso with penalty parameter λ1se (selected via leave-
one-out cross-validation) for the Cox model with death as the sole endpoint (transplants censored), resulted
in a model adjusted for histological stage, previous gastrointestinal bleeding, serum bilirubin, serum albu-
min, weight, age and sex. No significant treatment effect was found (p = 0.23). The double selection
method with penalty parameter λ1se additionally included the variables hospital (7 levels) and creatinine,
which also did not render the treatment effect on time to death significant (p = 0.13). In the model for
progression to death or transplantation, only histological stage, serum bilirubin, serum albumin and sex
were selected by post-Lasso and a significant treatment effect was found (p = 0.02). The double selection
method (with penaly parameter λ1se) additionally included the variables hospital and creatinine, and also
resulted in a significant treatment effect (p = 0.02).
Figure 11 in Appendix B compares the standardized survival curves based on the post-Lasso and
double selection to the unadjusted survival curves, under CyA and placebo and for both endpoints. The
standardized survival curves showed an attenuated difference in survival compared to the survival curves
without accounting for any covariates. This difference was most pronounced under treatment with CyA.
Under placebo the standardized survival curves based on post-Lasso and double selection were nearly
identical, while a (rather small) difference between the standardized survival curves was observed under
treatment with CyA. This was expected based on the simulation results.
8 Discussion
In this paper, we aimed to improve on the standard practice of conducting tests of the null hypothesis of no
treatment effects in randomized controlled trials with time-to-event endpoints. The next step is to obtain
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valid estimates of treatment effect along with valid confidence intervals. The method we have proposed in
this paper is readily applicable for this. In particular, the treatment effect is directly obtained from the
final Cox model for survival T on treatment A and the union of the sets of variables selected in the two
variable selection steps. A theoretically justified but more involved procedure is the method proposed by
Fang et al. (2017).
The results in this paper have implications for protocol writing. While one may be concerned that the
covariates that will be adjusted for are difficult to prespecify in a protocol, one need not to decide in advance
which variables to adjust for, but rather how variable selection will be done. Specifically, as long as the
variable selection approach is pre-specified and works along the lines of our proposal, the analysis is pre-
specified and there is no risk of inflating the Type I error. We recommend using the Lasso in combination
with cross-validation in the two selection steps. Although Lasso is less common in survival analyses in
randomized trials, software for penalized maximum likelihood estimation has become increasingly available
to statisticians. It is hereby important that the choice of the penalty parameter, which is based on cross-
validation, is also discussed in the protocol. As our proposal seems to perform better with the largest value
of the penalty parameter such that the error is within 1 standard error of the minimum (ie, λ1se), we suggest
using this choice of penalty parameter. That this choice of penalty is preferable is not surprising as we only
need the very strong predictors of censoring for collider bias to be impactful. We remind the reader that
the proposal extends to variable selection procedures other than the Lasso.
In our work, we so far did not consider the fact that the need for modelling also brings an increased
risk of model misspecification. Model misspecification turns out not to be a concern for testing the null
hypothesis of no treatment effect when censoring is either independent of the treatment conditional on the
covariates or independent of predictors of survival given the treatment group (e.g. Kong and Slud, 1997;
Lagakos and Schoenfeld, 1984; DiRienzo and Lagakos, 2001). However, our procedure needs the Cox model
to be correctly specified when censoring depends on both A and the predictors of survival. Although one
might see this as a limitation, some degree of modelling is unavoidable when adjusting makes for non-
informative censoring. Moreover, we conjecture that tests of the null hypothesis of no treatment effect will
continue to approach the nominal Type I error rate under model misspecification, though this remains to
be studied.
Note that, although adjustment generally makes the censoring assumption more plausible and thereby
leads to a higher chance of obtaining a valid test, there are settings where adjustment may make things
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worse. This is so in the causal diagram in Figure 7, where X is caused by two other (unmeasured) variables,
one a cause of C, the other a cause of T . Because X is a collider on a path from C to T , adjusting for
it may introduce selection bias, referred to as M-bias (Hernan and Robins, 2020). In our data analysis, we
assumed the absence of such variables. Also the selection of instruments (variables solely predictive of the
censoring mechanism in this case) is well known to be detrimental for (finite-sample) bias and efficiency
(Brookhart and van der Laan, 2006) and, where possible, is best avoided by eliminating them prior to the
data analysis based on subject-matter knowledge.
A TC
X
U1 U2
Figure 7: Example of M-bias. U1 and U2 are two unmeasured variables; one a cause of C, the other
a cause of T .
In this paper, we only considered adjustment for baseline covariates. In practice, there may also be time
dependent variables influencing survival and censoring. Remaining work is needed to adapt the procedure,
as time varying covariates should not be directly included in the Cox model for the event time of interest.
Augmented inverse probability of censoring weighting (AIPCW) (Robins and Rotnitzky, 1992; Scharfstein
et al., 1999), which is valid under selection of variables (Farrell, 2015), may then be preferable.
Appendix
Appendix A.1: Bias in Unadjusted Score Function
In this section we derive an expression for (the bias in) the score test statistic for the treatment effect in a
Cox proportional hazards model comparing two groups, without adjusting for any baseline covariate while
in fact one should. To develop further insight, suppose that
λ (t | X) = λ0(t)eβX .
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Here, λ0(t) is the true baseline hazard function and β is the true coefficient corresponding with the scalar
X. Likewise, suppose that the true model for censoring obeys
λC (t | A,X) = λC0 (t)eγ1A+γ2X ,
where λC0 (t) is the true baseline hazard function and γ1 and γ2 are the true coefficients corresponding with
A and X respectively. Without adjustment for X, the partial score function under the null hypothesis of
no treatment effect is given by
∫ ∞
0
(
A− E(A ·R(t))
E(R(t))
)
(dN(t)−R(t)λr0(t)dt) , (5)
where R(t) is the at risk indicator at time t, dN(t) the increment in the counting process N(t) at time t
and λr0(t) the unconditional baseline hazard at time t. The expected value of the score in Expression (5) is
then given by
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX
)
dt
−
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
) E (I(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX) dt
−
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλr0(t)dt
)
+
∫ ∞
0
E(A · I(T ≥ t)e−ΛC0 (t)eγ1A+γ2X )
E(I(T ≥ t)e−ΛC0 (t)eγ1A+γ2X )
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλr0(t)dt
)
,
(6)
where ΛC0 (t) =
∫ t
0
λC0 (s)ds is the cumulative baseline hazard for censoring and λ0(t)e
βX the true baseline
hazard for survival. As the latter two terms in Expression (6) both equal
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
)
λr0(t)dt,
Expression (6) reduces to
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX
)
dt
−
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
) E (I(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX) dt. (7)
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By using the fact that A ⊥ (T,X) -which is guaranteed to hold in a randomized trial under the null
hypothesis, it can be easily seen that (the bias in) the score is zero if either β = 0, γ1 = 0 or γ2 = 0. Using
a Taylor expansion, Expression (7) can be rewritten as
∫ ∞
0
E (AI(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t))− E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A
) E (I(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t))
 dt
+
∫ ∞
0
E (AI(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t)X)− E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A
) E (I(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t)X)
 dtβ
+
∫ ∞
0
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t)(−ΛC0 (t)eγ1A)X
)
+
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A
)2 E (I(T ≥ t)e−ΛC0 (t)eγ1A(−ΛC0 (t)eγ1A)X)E (I(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t))
−
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A(−ΛC0 (t)eγ1A)X
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A
) E (I(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t))
−
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A
) E (I(T ≥ t)e−ΛC0 (t)eγ1Aλ0(t)(−ΛC0 (t)eγ1A)X)
 dtγ2
+
∫ ∞
0
 ∂∂γ2 ∂∂βE
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX
)∣∣∣
β=0,γ2=0
− ∂
∂γ2
∂
∂β
E
(
AI(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
)
E
(
I(T ≥ t)e−ΛC0 (t)eγ1A+γ2X
) E (I(T ≥ t)e−ΛC0 (t)eγ1A+γ2Xλ0(t)eβX)
∣∣∣
β=0,γ2=0
 dtβγ2
+ higher order terms
It is straightforward to show that the integrand of the first integral is zero for each t. It can be shown that
the second and third integral are zero when A ⊥ (T,X). Similarly, it can be shown that the last integral
equals
− ΛC0 (t)λ0(t)
{
E
(
Ae−Λ
C
0 (t)e
γ1A
eγ1A
)
E
(
e−Λ
C
0 (t)e
γ1A
)
− E
(
Ae−Λ
C
0 (t)e
γ1A
)
E
(
e−Λ
C
0 (t)e
γ1A
eγ1A
)}
·{
E
(
I(T ≥ t)L2)E (I(T ≥ t))− E (I(T ≥ t)L)2}/{E (I(T ≥ t))E (e−ΛC0 (t)eγ1A)} ,
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so that (the bias in) the score is proportional to βγ2 up to higher order terms.
Appendix A.2: Censoring Assumptions
Here, we give a more formal proof of the validity of the unadjusted score test, without making assump-
tions about the underlying models for survival and censoring. In particular, we show that this score test
(which corresponds to the logrank test) is valid if censoring is either independent of treatment or survival
(conditional on treatment). The expectation of the partial score function in Equation (5) is
∫ ∞
0
E
{(
A− E(A ·R(t))
E(R(t))
)
R(t)E (dN(t) | FT (t),FC(t), A)
}
,
with FT (t) the history spanned by the counting process N(t) and FC(t) the history spanned by the counting
process NC(t) for censoring. First, we prove that the expectation has mean zero and hence provides a valid
test of the null hypothesis when censoring is independent of treatment. Note that in a randomized trial,
C ⊥ A and T ⊥ A implies that A ⊥ (C, T ). We will assume that A is independent of (C, T ), which
usually holds (in a randomized trial) under the null when A is independent of censoring. This, however,
wouldn’t hold in observational studies as there might be common causes of A and T . Therefore,
∫ ∞
0
E
{(
A− E(A ·R(t))
E(R(t))
)
R(t)E (dN(t) | FT (t),FC(t), A)
}
=
∫ ∞
0
E
{(
A− E(A · I(T ≥ t)I(C ≥ t))
E(I(T ≥ t)I(C ≥ t))
)
I(T ≥ t)I(C ≥ t)E (dN(t) | FT (t),FC(t))
}
=
∫ ∞
0
E
{(
A− E(A)E(I(T ≥ t)I(C ≥ t))
E(I(T ≥ t)I(C ≥ t))
)
I(T ≥ t)I(C ≥ t)E (dN(t) | FT (t),FC(t))
}
=0,
where the second and third equality follow from A ⊥ (C, T ).
Similarly, we prove that the expectation has mean zero and hence provides a valid test of the null
hypothesis when censoring is independent of survival in each treatment arm. Under the null hypothesis,
∫ ∞
0
E
{(
A− E(A ·R(t))
E(R(t))
)
R(t)E (dN(t) | FT (t),FC(t), A)
}
=
∫ ∞
0
E
{(
A− E(A · I(T ≥ t)I(C ≥ t))
E(I(T ≥ t)I(C ≥ t))
)
I(T ≥ t)I(C ≥ t)E (dN(t) | FT (t))
}
=
∫ ∞
0
E
{(
A− E(A · I(C ≥ t))
E(I(C ≥ t))
)
I(T ≥ t)I(C ≥ t)E (dN(t) | FT (t))
}
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=∫ ∞
0
(
E(AI(C ≥ t))− E(A · I(C ≥ t))E(I(C ≥ t))
E(I(C ≥ t))
)
E(I(T ≥ t)E (dN(t) | FT (t)))
= 0.
Here, the second equality follows from E(A · I(T ≥ t)I(C ≥ t)) = E(A · I(C ≥ t))E(I(T ≥ t)) by the
assumption that T ⊥ C | A and E(I(T ≥ t)I(C ≥ t)) = E(I(C ≥ t))E(I(T ≥ t)) by the fact that
assumption T ⊥ C | A also implies that T ⊥ C under the null hypothesis in a randomized trial. The third
equality follows from the same assumption(s).
Thus, as commonly known the log-rank test is valid under the null hypothesis if censoring is non-
informative - namely, if censoring is (statistically) independent of survival time. It is more surprising that
its validity under the null is maintained even if censoring does depend on survival time, as long as A is
jointly independent of C and T .
Appendix A.3: Method by Fang et al. (2017)
Fang et al. (2017) propose a decorrelated score test for H0 : α = 0, as follows. First, they estimate β as βˆ
by fitting a Cox model for survival time T on treatment A and baseline covariates X using Lasso. Next,
they linearly regress ∫ τ
0
(
Ai −
∑n
i=1 Ri(t)Aie
βˆ′Li∑n
i=1 Ri(t)e
βˆ′Li
)
dNi(t)
on ∫ τ
0
(
Li −
∑n
i=1 Ri(t)Lie
βˆ′Li∑n
i=1 Ri(t)e
βˆ′Li
)
dNi(t),
using Lasso and with βˆ the Lasso estimates obtained in the previous step. Here, τ denotes the end-of-study
time. Denoting the p-dimensional (estimated) linear regression coefficient from the previous step by wˆ, they
propose the following decorrelated score function for α
Uˆ(α, βˆ) = − 1
n
n∑
i=1
∫ τ
0
[
Ai − wˆ′Xi −
{∑n
i=1 Ri(t)Aie
αAi+βˆ
′Xi∑n
i=1 Ri(t)e
αAi+βˆ′Xi
− wˆ′
∑n
i=1 Ri(t)Xie
αAi+βˆ
′Xi∑n
i=1 Ri(t)e
αAi+βˆ′Xi
}]
dNi(t).
To test the null hypothesis α = 0, they standardize Uˆ(0, βˆ) to construct the test statistic. For further
details, we refer the reader to Fang et al. (2017).
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Appendix B: Figures and Tables
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(a) β = 0.2, γ2 = 0.2 (b) β = 2.2, γ2 = 0.2 (c) β = 0.2, γ2 = 2.2
(d) β = 0.5, γ2 = 0.5 (e) β = 2.2, γ2 = 0.5 (f) β = 0.5, γ2 = 2.2
(g) β = 0, γ2 = 2.2 (h) β = 2.2, γ2 = 0 (i) β = 2.2, γ2 = 2.2
Figure 8: Distribution of the logrank test statistic compared to the standard normal distribution
(black, solid) for different values of β, γ2 and γ1. Red, dashed : γ1 = 0; Blue, dotted: γ1 = 1;
Green, dotted-dashed: γ1 = 2; Gray, long dashed: γ1 = 3. Results are based on 10, 000 simulations,
n = 100, X ∼ N(0, 1), λ0(t) = e and λC0 (t) = e−1.
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Figure 9: Empirical Type I error rate at the 5% significance level of the Lasso and the proposed
double selection method under Setting 2. Row 1: double selection method with penalty parameter
λ1se; Row 2: double selection method with penalty parameter λmin; Row 3: Post-Lasso with penalty
parameter λ1se ; Row 4: Post-Lasso with penalty parameter λmin. Left: γ1 = 0; Middle: γ1 = 1;
Right: γ1 = 3. Results are based on 1, 000 simulations, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
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Figure 10: Empirical Type I error rate at the 5% significance level of the Lasso and the proposed
double selection method under Setting 3. Row 1: double selection method with penalty parameter
λ1se; Row 2: double selection method with penalty parameter λmin; Row 3: Post-Lasso with penalty
parameter λ1se ; Row 4: Post-Lasso with penalty parameter λmin. Left: γ1 = 0; Middle: γ1 = 1;
Right: γ1 = 3. Results are based on 1, 000 simulations, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
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(a) All deaths (transplants censored); under
placebo.
(b) All deaths (transplants censored); under
CyA.
(c) Progression to death or transplant; under
placebo.
(d) Progression to death or transplant; under
CyA.
Figure 11: Unadjusted survival curves and adjusted/standardized survival curves based on the
post-Lasso and double selection models for the PBC-3 dataset. Unadjusted: unadjusted survival
curves; Double Selection: standardized survival curves based on double selection model with penalty
parameter λ1se; Lasso: standardized survival curves based on Post-Lasso model penalty parameter
λ1se .
28
(a) b = 0 (b) b = 0.8
(c) b = 1.6 (d) b = 2.4
Figure 12: True survival probabilities, unadjusted (Kaplan-Meier based) survival probabilities and
adjusted/standardized survival probabilities based on the post-Lasso and double selection models
evaluated at 1 year. Results are shown for A = 1 based on 1, 000 simulations under Setting
1 (see Section 4), n = 400, p = 30, γ1 = 0, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
Truth: True survival probabilities; Unadjusted: unadjusted/Kaplan-Meier survival probabilities;
Double Selection: standardized survival probabilities based on double selection model with penalty
parameter λ1se; Double Selection Min: standardized survival probabilities based on double selection
model with penalty parameter λmin; Lasso: standardized survival probabilities based on Post-Lasso
model penalty parameter λ1se; Lasso Min: standardized survival probabilities based on Post-Lasso
model with penalty parameter λmin.
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(a) b = 0 (b) b = 0.8
(c) b = 1.6 (d) b = 2.4
Figure 13: True survival probabilities, unadjusted (Kaplan-Meier based) survival probabilities and
adjusted/standardized survival probabilities based on the post-Lasso and double selection models
evaluated at 1 year. Results are shown for A = 1 based on 1, 000 simulations under Setting
1 (see Section 4), n = 400, p = 30, γ1 = 1, λ0(t) = 1 (β0 = 0) and λ
C
0 (t) = 1 (γ0 = 0).
Truth: True survival probabilities; Unadjusted: unadjusted/Kaplan-Meier survival probabilities;
Double Selection: standardized survival probabilities based on double selection model with penalty
parameter λ1se; Double Selection Min: standardized survival probabilities based on double selection
model with penalty parameter λmin; Lasso: standardized survival probabilities based on Post-Lasso
model penalty parameter λ1se; Lasso Min: standardized survival probabilities based on Post-Lasso
model with penalty parameter λmin.
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